Do SGLT2 inhibitors prevent preclinical diabetic retinopathy? A Prospective Pilot Optical Coherence Tomography Angiography Study

PURPOSE To evaluate the effects of metformin alone and combined treatment with metformin and an SGLT2 inhibitor on retinal microvascular morphology using optical coherence tomography angiography (OCTA) in isolated type 2 diabetes mellitus (DM) patients with HbA1c above the expected target (>7%). METHODS Fifty patients with isolated DM, 7%

Keywords:

• Glycemic
• Urology
• Empagliflozin
• optical coherence tomography angiography
• Retinal
• Metformin
• Type 2 Diabetes Mellitus
• Medicine
• Diabetic retinopathy
• Diabetes mellitus

• Correction
• Source
• Cite
• Save
• Machine Reading By IdeaReader